A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

The social impairments of autism spectrum disorder (ASD) have a major impact on quality of life, yet there are no medications that effectively treat these core social behavior deficits. Preclinical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian soci...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Transl Med
Autori principali: Parker, Karen J., Oztan, Ozge, Libove, Robin A., Mohsin, Noreen, Karhson, Debra S., Sumiyoshi, Raena D., Summers, Jacqueline E., Hinman, Kyle E., Motonaga, Kara S., Phillips, Jennifer M., Carson, Dean S., Fung, Lawrence K., Garner, Joseph P., Hardan, Antonio Y.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716148/
https://ncbi.nlm.nih.gov/pubmed/31043522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aau7356
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi